 |
| Greg Voyles |
Greg Voyles, who was most recently VP, commercial solutions at Syneos Health, joins Imre as chief growth officer.
Prior to Syneos Health, he served as chief operating officer at Vertical Pharmaceuticals and chief commercial officer at Osmotica Pharmaceutical.
In his new role, Voyles will lead the agency’s growth strategy—overseeing business development, reputation management and marketing initiatives.
Imre says that Voyle’s appointment highlights the agency’s commitment to continued growth as a healthcare agency of record across HCP and DTC assignments, with a focus on new offerings that harness Generative AI for marketing effectiveness in the biopharma sector.
“Greg's experience across many sides of the customer equation can help brands be more nimble in adopting new ways to win and serve,” said Imre president Anna Kotis. “He will play a key role as we steward our brands and business into this new Gen AI era in our industry.”
Imre is No. 8 on O'Dwyer's rankings of healthcare PR firms with fee income of $55M during 2024.
TikTok brings on Jori Arancio as head of global consumer & B2B communications, according to a report on Deadline.
Avoq appoints partners Whit Askew and Cedric Grant to manage its government relations operations... rbb Communications, names VPs Jennifer Valdes and Julie Jimenez-Padron as equity shareholders... The Consultancy PR promotes Francesco Tribuzio to SVP.
MAD Global Strategy hires Actum's Brent Petrone as SVP... Jasper, an AI marketing platform, appoints Alex Barrera as chief revenue officer and Lisa Hopkins as VP of partnerships... Altair Law, a San Francisco-based trial litigation firm, appoints Stephen Walton as CMO.
Burson chair AnnaMaria DeSalva announced via LinkedIn that she is stepping down on June 30 after a year of service, and five years at the helm of its Hill & Knowlton subsidiary.
Kristofer Kirk, who has more than 18 years of digital communications experience, has joined Infinite as US head of integrated campaigns.
Have a comment? Send it to 
No comments have been submitted for this story yet.